Publications by authors named "Nursen Cigerci Gunaydin"

Background: Pandemic period may affect aeroallergen sensitization.

Objective: The study aimed to investigate changes in allergen sensitivities of skin prick test (SPT) in patients with allergic rhinitis (AR) during pandemic and to evaluate relationship with disease severity.

Methods: In all, 164 AR patients with or without asthma, aged 6-17 years, who have undergone SPTs prior to the pandemic and after October 1, 2021 (18th month of the pandemic), were evaluated retrospectively.

View Article and Find Full Text PDF

Background: Food protein-induced allergic proctocolitis (FPIAP) is characterized by bloody stools in well-appearing infants. Zinc is a micronutrient that plays a crucial role in immune modulation and is essential for cellular function during immune response. Although there are studies on the assessment of intracellular zinc levels in allergic diseases, no data is available on erythrocyte zinc levels of patients with FPIAP.

View Article and Find Full Text PDF

Objective: The cut-off values for the skin prick test diameters and cow's milk-specific IgE measurements are used to predict the result of the oral food challenge test for the diagnosis of cow's milk allergy. This study aimed to determine the diagnostic values of skin prick test and cow's milk-specific IgE according to age groups and compare the diagnostic powers of these 2 methods.

Materials And Methods: In total, 153 children who had a preliminary diagnosis of cow's milk allergy were evaluated.

View Article and Find Full Text PDF

Background: Oral immunotherapy (OIT) is a novel allergen-specific treatment for food allergies.

Objective: To investigate the effect of OIT on blocking antibodies, T cell regulation, and cytokine response during immunoglobulin (Ig)E-mediated cow's milk allergy (CMA) treatment.

Methods: A total of 59 children with IgE-mediated CMA who were followed in pediatric allergy outpatient clinic and 18 healthy children were included.

View Article and Find Full Text PDF
Article Synopsis
  • Severe IgE-mediated reactions pose significant challenges during oral immunotherapy (OIT) for cow's milk allergy in children, with 73.8% experiencing adverse reactions during the build-up phase.
  • A study of 86 children showed a decrease in reactions from the build-up phase to the maintenance phase, highlighting the importance of monitoring symptoms like cough during food challenges.
  • Key biomarkers, such as higher levels of specific immunoglobulin E (sIgE) and younger age at the onset of OIT, can help identify patients at increased risk for severe reactions.
View Article and Find Full Text PDF

Objective: Cow's milk (CM) contains some proteins capable of causing an allergic reaction in a sensitized individual and one of the most common causes of food allergy in childhood. Most of the patients will develop tolerance by the age of 3. In this study, we aimed to evaluate sensitivity to CM allergen components as well as goat's milk (GM) and sheep's milk cross reactions in cow's milk allergic (CMA) patients and to figure out the risk factors for tolerance non-development.

View Article and Find Full Text PDF

Background: Urticaria can be the only sign of a food allergy or can be seen together with other signs and symptoms of a food allergy.

Objective: To determine the demographic, etiologic, and clinical features of food-induced acute urticaria in childhood.

Methods: Patients suspected of food-induced acute urticaria were included in this prospective cross-sectional multicenter study.

View Article and Find Full Text PDF

Recombinant factor VIIa (rFVIIa) is a highly purified recombinant protein. It is approved for the treatment and prevention of bleeding episodes associated with congenital factor VII deficiency, congenital hemophilia with inhibitors, and Glanzmann's thrombasthenia. The most commonly reported adverse events are thrombolytic in nature.

View Article and Find Full Text PDF
Article Synopsis
  • Oral immunotherapy can effectively increase the tolerance levels in children with cow's milk allergy, making it a viable treatment option in pediatric allergy clinics.
  • A study involving 42 patients showed that the average age to start treatment was around 3.3 years, with mild to moderate adverse reactions occurring in 38% of cases during the therapy.
  • Factors like age and specific immunoglobulin-E levels didn't significantly predict adverse reactions, but patients with a history of anaphylaxis experienced more reactions during the treatment.
View Article and Find Full Text PDF

Common variable immunodeficiency (CVID) and immunoglobulin A deficiency (IgAD) are the most prevalent primary immunodeficiency disorders. High rates of familial inheritance have been described in CVID and IgAD, but it is unknown in different ethnic populations. We aimed to determine the prevalence of familial cases and whether they showed more severe clinical characteristics than sporadic ones in Turkish patients.

View Article and Find Full Text PDF

Background: Horse antithymocyte globulin (h-ATG) (ATGAM(®) ) is the first choice of treatment in very severe patients with aplastic anemia who do not have any HLA matched sibling donor. h-ATG is a heterologous serum that may cause anaphylaxis. Alternative treatment strategies must be planned in case of hypersensitivity.

View Article and Find Full Text PDF